ARA-290

Specification:10mg
MOQ:1Box

ARA-290, also known as Cibinetide, is a small, erythropoietin (EPO)-derived peptide designed to harness the tissue-protective and anti-inflammatory effects of EPO without causing hematopoiesis (red blood cell production). It works by selectively activating the innate repair receptor (IRR) to reduce inflammation and pain in conditions like diabetic neuropathy, sarcoidosis, and other types of nerve injury. ARA-290 aims to offer long-term relief of neuropathic pain and improve metabolic function, and has been tested in clinical trials for these purposes.